REVIEW
|
doi:10.20944/preprints202401.1546.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Claudin; monoclonal antibodies; adenocarcinoma; targeted therapy; CAR-T cell therapy
Online: 22 January 2024 (10:02:04 CET)